stella
beta
A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting — Stella
Recruiting
Back to Chronic Lymphocytic Leukemia (CLL) trials
Trial locations
(1 site)
United States
Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, Wisconsin
View full record on ClinicalTrials.gov